ResMed| (RMD)Stephens Investment Management Group LLC reduced its stake -227K shares

46K

Shares reported · -227K vs prior quarter

0.10%

Disclosed portfolio weight

$8.96M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of RMD — reported range $1,001 - $15,000
2. Jun 4, 2026FDAFDA device clearance: Orion
3. Jun 8, 2026InsiderCEO sold ~$968K of RMD shares in the open market
4. Jun 25, 2026FDARecall: Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than…
5. Jun 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
6. Jul 7, 2026InsiderCEO sold ~$1.09M of RMD shares in the open market

What came next

1. Aug 5, 2026InsiderDirector sold ~$1.8M of RMD shares in the open market
2. Aug 6, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
3. Aug 7, 20265% stakeAustralianSuper Pty Ltd reported a passive stake (13G) of 5.7%
4. Aug 7, 2026InsiderCEO sold ~$1.03M of RMD shares in the open market
5. Aug 13, 2026Company filing · Form 8-K · Auditor change, Executive changeChanged its auditor, and changed a top executive or board member (and 1 more item)“On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.”
6. Aug 27, 2026FDAFDA device clearance: EasyCare Tx 2
7. Sep 2, 2026InsiderDirector sold ~$228K of RMD shares in the open market
8. Sep 8, 2026InsiderCEO sold ~$1.11M of RMD shares in the open market
9. Oct 7, 2026InsiderCEO sold ~$1.13M of RMD shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for ResMed|

For ResMed|, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 19 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

How this filing works

• SEC Form 13F

Other disclosures at ResMed|

• SEC Form 4Oct 8, 2026
• SEC Form 144Oct 7, 2026
• SEC Form 4Sep 10, 2026
• SEC Form 144Sep 8, 2026
• SEC Form 4Sep 4, 2026
• SEC Form 144Sep 2, 2026

Everything OQRO holds on this company is on its RMD page.